Alternative data datasets
Browse by provider, category, marketplace, access, delivery and license
View source information and access options.
A free forward catalyst calendar for clinical-stage biotech assets
Clinical Trials Version History The Clinical Trials Version History dataset by Anamnesis Data: structured medical and scientific data for biotech, pharma and healthcare research. Public trial registries show only a trial's latest state. This dataset keeps every version, so you can see what a trial said on any past date, or when a sponsor moved a completion date. 606,620 trials (4,456,781 versions)
Clinical Trials Version History: Sample A free sample of the Clinical Trials Version History dataset by Anamnesis Data: structured medical and scientific data for biotech, pharma and healthcare research. Public trial registries show only a trial's latest state. This dataset keeps every version, so you can see what a trial said on any past date, or when a sponsor moved a completion date. The sample
This dataset has moved to anamnesis-data/clinical_trials_history. New releases are published there only; this repository is no longer updated. Access approvals do not carry over, so please request access on the new repository. Existing tags here (up to v2026.09.26) remain available for pinned use. ClinicalTrials.gov Version History A longitudinal, per-version snapshot of every protocol amendment e
A free forward catalyst calendar for clinical-stage biotech assets
IQVIA's Pharmetrics medical-claims dataset marketed on Snowflake Marketplace, offering United States healthcare billing records for pharmaceutical and biotechnology research.
Metadata for hundreds of thousands of clinical trials in English, French and Spanish, structured in Parquet with study-level fields such as phase, condition, sponsor and status (Apache 2.0). Trial starts and phase transitions lead clinical development, so this works as an early indicator of biotech pipeline activity.
Data for the COVID-19 clinical trials registered in the US
A 10% sample of over 573,000 ClinicalTrials.gov studies augmented with AI-classified therapeutic areas, sponsor categorization, outcome groupings, and duration metrics, offered for portfolio and market landscape analysis.